This is a preview of subscription content, log in via an institution to check access.
Reference
Romeo R, et al. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial. British Journal of Psychiatry : 20 Dec 2012. Available from: URL: http://dx.doi.org/10.1192/bjp.bp.112.115212
Additional information
* the Health Technology Assessment Study of the Use of Antidepressants for Depression in Dementia (HTA-SADD)
** 2009/2010 values
Rights and permissions
About this article
Cite this article
Mirtazapine cost effective for depression in dementia?. PharmacoEcon Outcomes News 670, 7 (2013). https://doi.org/10.1007/s40274-013-0097-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0097-z